Press Releases

Sep 27, 2023

Veracyte Names Phillip G. Febbo, M.D., as Chief Scientific Officer and Chief Medical Officer

Read More

Sep 21, 2023

Veracyte Announces Novel Afirma-Based Findings that Advance Molecular Understanding of Thyroid Cancer to Be Presented at the 2023 ATA Annual Meeting

Read More

Sep 07, 2023

Veracyte Names Marie-Claire Taine, Ph.D., as General Manager of Its IVD Business Unit To Advance Global Expansion of the Company’s Tests

Read More

Sep 06, 2023

Veracyte and Gustave Roussy Announce Collaboration to Help Biopharmaceutical Companies Accelerate Development of Novel Cancer Therapies

Read More

Aug 29, 2023

Veracyte to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

Read More

Aug 22, 2023

Veracyte Announces that Findings Published in JCO Precision Oncology Suggest Potential of Decipher GRID-Derived Gene Signatures to Predict Treatment Response in Recurrent Prostate Cancer

Read More

Aug 15, 2023

Veracyte Earns Top Workplace Awards in the San Francisco Bay Area and San Diego

Read More

Aug 10, 2023

C2i Genomics and Ichilov Join Forces to Bring Cancer Detection and Monitoring Platform to Israel

Read More

Aug 08, 2023

Veracyte Announces Second Quarter 2023 Financial Results

Read More

Aug 01, 2023

Study Published in JNCI Cancer Spectrum Demonstrates Real-World Utility of Veracyte’s Decipher Prostate Genomic Classifier in Prostate Cancer Treatment

Read More